Comprehensive Blood Analysis in COVID-19 Patients
Corresponding Organization : Maastricht University
Variable analysis
- None explicitly mentioned
- Leukocyte count
- Platelet count
- Hemoglobin
- Hematocrit
- Prothrombin time (PT)
- Activated partial thromboplastin time (aPTT)
- Fibrinogen concentration
- D-dimer concentration
- Anti-Xa activity
- Bilirubin
- Creatinine
- EDTA blood used for complete blood count measurements
- 3.2% citrated blood used for PT, aPTT, fibrinogen, D-dimer, and Anti-Xa activity measurements
- COVID-19 patient samples diluted three times with reference pooled plasma for Anti-Xa activity measurement
- Anti-Xa activity determined using an LMWH calibration line
- UFH activity subsequently calculated using a previously determined formula
- Bilirubin and creatinine measurements performed in serum on a COBAS® 8000 analyzer
- None explicitly mentioned
- None explicitly mentioned
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!